Skip to Content

Cetuximab

In the US, Cetuximab (cetuximab systemic) is a member of the drug class EGFR inhibitors and is used to treat Colorectal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer and Squamous Cell Carcinoma.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC06

CAS registry number (Chemical Abstracts Service)

0205923-56-4

Chemical Formula

C6484-H10042-N1732-O2023-S36

Molecular Weight

145782

Therapeutic Categories

Cytostatic agent

Immunomodulator

Monoclonal antibody against epidermal growth factor receptor

Chemical Name

Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer (WHO)

Foreign Names

  • Cetuximabum (Latin)
  • Cetuximab (German)
  • CĂ©tuximab (French)
  • Cetuximab (Spanish)

Generic Names

Brand Names

  • Cetuximab Baxter
    Baxter, New Zealand
  • Erbitux
    ImClone, Canada; ImClone, United States; Inter-Lab Ltd, Israel; Merck, Bosnia & Herzegowina; Merck, Belgium; Merck, Brazil; Merck, Colombia; Merck, Czech Republic; Merck, Denmark; Merck, Ecuador; Merck, Estonia; Merck, Egypt; Merck, Finland; Merck, Greece; Merck, Hong Kong; Merck, Croatia (Hrvatska); Merck, Indonesia; Merck, South Korea; Merck, Lithuania; Merck, Mexico; Merck, Malaysia; Merck, Norway; Merck, Philippines; Merck, Poland; Merck, Serbia; Merck, Sweden; Merck, Slovakia; Merck, Thailand; Merck, Tunisia; Merck, Turkey; Merck, Venezuela; Merck KGAA, Cyprus; Merck KGAA, Iceland; Merck KGAA, Lebanon; Merck KGAA, Macedonia; Merck KGAA, Portugal; Merck KGAA, Romania; Merck KGAA, Vietnam; Merck Pharma, Italy; Merck S.L., Spain; Merck Sereno, Latvia; Merck Serono, Argentina; Merck Serono, China; Merck Serono, Germany; Merck Serono, France; Merck Serono, United Kingdom; Merck Serono, Ireland; Merck Serono, Japan; Merck Serono, Taiwan; Merck Serono, South Africa; Pharmacy Retailing, New Zealand; Merck Merck Serono Division, Singapore
  • Erbitux 100mg/20ml
    Merck, Switzerland
  • Erbitux 500mg/100ml
    Merck, Switzerland
  • Erbitux 5mg/ml
    Abacus, Austria; Haemato Pharm, Austria; Merck, Austria; Merck, Hungary; Merck, Luxembourg; Merck Serono, Australia; Orifarm, Austria

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.